✦ LIBER ✦

P.1.013 The cannabinoid-1 receptor antagonist rimonabant increases striatal dopamine D2/3 receptor availability in rats

✍ Scribed by E. van de Giessen; C. Crunelle; S. Schulz; L. Vanderschuren; K. de Bruin; W. van den Brink; J. Booij

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cannabinoid-1 receptor antagonist rimona

✍ Cleo L. Crunelle; Elsmarieke van de Giessen; Sybille Schulz; Louk J. M. J. Vande 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB

Dopamine D1 receptor stimulation increas

✍ Geert Damsma; Chui-Se Tham; George S. Robertson; Hans C. Fibiger 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 229 KB

D-1 / D-2 behavioural interactions in th

✍ Michael S. Starr 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 358 KB

Antagonistic cannabinoid CB1/dopamine D2

✍ Daniel Marcellino; Paulina Carriba; Malgorzata Filip; Anders Borgkvist; Malgorza 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 546 KB

Catalepsy produced by striatal microinje

✍ James K. Rowlett; Norman W. Pedigo Jr.; Michael T. Bardo 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 643 KB

Repeated administration of a dopamine D1

✍ Takahide Shuto; Philip Seeman; Mahomi Kuroiwa; Akinori Nishi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB